Literature DB >> 31228288

Reply to 'Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not standard of care for patients with colorectal peritoneal metastases' by Julianov and Saroglu.

Loek A W de Jong1, Nielka P van Erp1.   

Abstract

Entities:  

Keywords:  oncology; pharmacodynamics; pharmacokinetics

Mesh：

Substances：

Year:  2019        PMID： 31228288      PMCID： PMC6624379          DOI： 10.1111/bcp.13983

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Reply to 'Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not standard of care for patients with colorectal peritoneal metastases' by Julianov and Saroglu.

Authors:  Loek A W de Jong; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2019-06-22       Impact factor: 4.335

2.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not the standard of care for patients with colorectal peritoneal metastases.

Authors:  Alexander Julianov; Azize Saroglu
Journal:  Br J Clin Pharmacol       Date:  2019-04-25       Impact factor: 4.335

Review 3.  Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.

Authors:  Loek A W de Jong; Fortuné M K Elekonawo; Philip R de Reuver; Andre J A Bremers; Johannes H W de Wilt; Frank G A Jansman; Rob Ter Heine; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2018-10-25       Impact factor: 4.335

4.  Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.

Authors:  V Leung; Y R Huo; W Liauw; D L Morris
Journal:  Eur J Surg Oncol       Date:  2016-10-13       Impact factor: 4.424

5.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

6.  The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

Authors:  Arancha Prada-Villaverde; Jesus Esquivel; Andrew M Lowy; Maurie Markman; Terence Chua; Joerg Pelz; Dario Baratti; Joel M Baumgartner; Richard Berri; Pedro Bretcha-Boix; Marcello Deraco; Guillermo Flores-Ayala; Olivier Glehen; Alberto Gomez-Portilla; Santiago González-Moreno; Martin Goodman; Evgenia Halkia; Shigeki Kusamura; Mecker Moller; Guillaume Passot; Marc Pocard; George Salti; Armando Sardi; Maheswari Senthil; John Spiliotis; Juan Torres-Melero; Kiran Turaga; Richard Trout
Journal:  J Surg Oncol       Date:  2014-08-02       Impact factor: 3.454

7.  A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.

Authors:  Edward A Levine; Konstantinos I Votanopoulos; Perry Shen; Greg Russell; Joyce Fenstermaker; Paul Mansfield; David Bartlett; John H Stewart
Journal:  J Am Coll Surg       Date:  2018-01-10       Impact factor: 6.113

8.  The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.

Authors:  D Hompes; A D'Hoore; A Wolthuis; S Fieuws; B Mirck; S Bruin; V Verwaal
Journal:  J Surg Oncol       Date:  2013-12-28       Impact factor: 3.454

9.  Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.

Authors:  Judith E K R Hentzen; Koen P Rovers; Hendrien Kuipers; Willemijn Y van der Plas; Lukas B Been; Frederik J H Hoogwater; Robert J van Ginkel; Patrick H J Hemmer; Gooitzen M van Dam; Ignace H J T de Hingh; Schelto Kruijff
Journal:  Ann Surg Oncol       Date:  2019-03-15       Impact factor: 5.344

Review 10.  Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.

Authors:  Can Yurttas; Giulia Hoffmann; Alexander Tolios; Sebastian P Haen; Matthias Schwab; Ingmar Königsrainer; Alfred Königsrainer; Stefan Beckert; Markus W Löffler
Journal:  J Clin Med       Date:  2018-12-19       Impact factor: 4.241
View more
  1 in total

1.  Reply to 'Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not standard of care for patients with colorectal peritoneal metastases' by Julianov and Saroglu.

Authors:  Loek A W de Jong; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2019-06-22       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.